Clearline Capital’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-68,791
Closed -$10.1M 118
2026
Q1
$10.1M Buy
+68,791
New +$11.2M 0.53% 41
2024
Q1
Sell
-3,600
Closed -$380K 134
2023
Q4
$380K Buy
+3,600
New +$393K 0.02% 93
2017
Q2
Sell
-143,100
Closed -$6.38M 49
2017
Q1
$6.38M Buy
+143,100
New +$5.96M 3.02% 11

Other funds holding ORCL

Clearline Capital's ORCL Position: Q2 2026 in Review

Clearline Capital sold out of Oracle (ORCL) in Q2 2026, closing a stake of 68,791 shares — an estimated $10.1M sold.

Clearline Capital first reported a position in ORCL in Q1 2017 and held it in 3 quarters. The position peaked at $10.1M in Q1 2026. 3,519 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Clearline Capital reported no remaining Oracle position as of Q2 2026 after selling out during the quarter.
  • Clearline Capital sold 68,791 Oracle shares in Q2 2026, an estimated $10.1M.
  • Clearline Capital first reported a position in Oracle in Q1 2017 and held it in 3 quarters.
  • Clearline Capital's Oracle position peaked at $10.1M in Q1 2026.
  • 3,519 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Clearline Capital's 13F filing for Q2 2026, filed 14 Aug 2026.